Abstract:Allergen exposure chamber (AEC) challenge effectively evaluates timothy grass allergy in rhinitis patients. Symptom severity reproducibly correlates with timothy grass pollen concentrations. AEC challenge can be plausible for allergy diagnostics and patient stratification in clinical research. AEC, allergen exposure chamber; AR, allergic rhinitis; ARM, acoustic rhinometry; FEV1, forced expiratory volume in the first second; HC, healthy control; p/m3, particles/cubic meter; MCA, minimal cross‐sectional area; PEFR, peak expiratory flow rate; PNIF, peak nasal inspiratory flow; TNSS, total nasal symptom score. Background The fluctuation in concentrations of airborne allergens frequently presents a challenge to assessing the efficacy of allergen immunotherapy (AIT) in 'field' studies. Allergen exposure chambers (AECs) are specialized medical installations developed to expose individuals to allergens at defined and consistent concentrations under a controlled environment. The aim of the study was to validate the provocation test with timothy grass pollen as well as to assess its safety in the AEC in patients with allergic rhinitis. Methods In the ALLEC® AEC, varying concentrations of timothy grass pollen were dispersed. Allergic symptoms were measured by total nasal symptom score (TNSS), acoustic rhinometry, peak nasal inspiratory flow (PNIF) and nasal discharge volume. Lung function, assessed through peak expiratory flow rate (PEFR) and forced expiratory volume in the first second (FEV1), was used to evaluate safety. Results The consistency of the test was proved by the stability of environmental conditions, including temperature, humidity and CO2 levels, as well as constant concentrations of grass pollen at predetermined levels ranging from 1000 to 10,000 particles per cubic meter (p/m3). Allergic individuals developed symptoms at concentrations of 3000 p/m3 and above, across all measured endpoints. Lung function was not affected throughout all the challenges. The reproducibility of symptoms was confirmed throughout the tests. The concentration of 8000 p/m3 together with a challenge duration of 120 min was found to be optimal. Conclusion The study demonstrates that the ALLEC® grass pollen exposure chamber provides a reliable and safe method for inducing repeatable symptoms in patients with allergic rhinitis. This approach can be effectively applied for allergy diagnostics and clinical endpoint determination during AIT.

Microarray-based evaluation of selected recombinant timothy grass allergens expressed in E. Coli and N. Benthamiana

Rapid production of recombinant allergens in Nicotiana benthamiana and their impact on diagnosis and therapy

Clinical validation of grass pollen exposure chamber in patients with allergic rhinitis triggered by timothy grass

Qualitative and quantitative comparison of allergen component-specific to birch and grass analyzed by ImmunoCAP assay and Euroline immunoblot test

Development of Multiplex PCR Coupled DNA Chip Technology for Assessment of Endogenous and Exogenous Allergens in GM Soybean

Standardisation of allergen products: 4. Validation of a candidate European Pharmacopoeia standard method for quantification of major grass pollen allergen Phl p 5

Production of hypoallergenic plant foods by selection, breeding and genetic modification

Component-resolved diagnosis for phleum allergy: the role of recombinants

Physicochemical and immunological characterization of Amb a 12, a novel ragweed (Ambrosia artemisiifolia) pollen allergen

Identification of a Plasma Mirna Biomarker Signature for Allergic Asthma: A Translational Approach

A novel glycocluster molecule prevents timothy-induced allergic airway inflammation in mice

Identification of cross-reactive IgE-binding proteins from Philippine allergenic grass pollen extracts

Allergenicity Assay of Allergen from Dermatophagoides Farinae in Transgenic Tobacco

Major Pollen Allergen Components and CCD Detection in Bermuda Grass Sensitized Patients in Guangzhou, China

Expression and Characterization of Functional Recombinant Bet v 1.0101 in the Chloroplast of Chlamydomonas reinhardtii

Rapid generation of an RBL cellular model to study proteins that cause allergenic reactions in vitro

Production of a recombinant protein from Alternaria containing the reported N-terminal of the Alt a1 allergen

Impact of elevated air temperature and drought on pollen characteristics of major agricultural grass species

Production of recombinant Cladosporium herbarum allergen Cla h8 and investigation on its immunological activities

Three patterns of sensitization to mugwort, timothy, birch and their major allergen components revealed by Latent class analysis

A Cell-Free Protein Synthesis Platform to Produce a Clinically Relevant Allergen Panel